FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103071556> ?p ?o ?g. }

• W2103071556 endingPage "449" @default.
• W2103071556 startingPage "440" @default.
• W2103071556 abstract "Epidemiologic studies demonstrate that long-term use of NSAIDs is associated with a reduced risk for the development of Alzheimer disease (AD). In this study, 20 commonly used NSAIDs, dapsone, and enantiomers of flurbiprofen were analyzed for their ability to lower the level of the 42-amino-acid form of amyloid β protein (Aβ42) in a human H4 cell line. Thirteen of the NSAIDs and the enantiomers of flurbiprofen were then tested in acute dosing studies in amyloid β protein precursor (APP) transgenic mice, and plasma and brain levels of Aβ and the drug were evaluated. These studies show that (a) eight FDA-approved NSAIDs lower Aβ42 in vivo, (b) the ability of an NSAID to lower Aβ42 levels in cell culture is highly predicative of its in vivo activity, (c) in vivo Aβ42 lowering in mice occurs at drug levels achievable in humans, and (d) there is a significant correlation between Aβ42 lowering and levels of ibuprofen. Importantly, flurbiprofen and its enantiomers selectively lower Aβ42 levels in broken cell γ-secretase assays, indicating that these compounds directly target the γ-secretase complex that generates Aβ from APP. Of the compounds tested, meclofenamic acid, racemic flurbiprofen, and the purified R and S enantiomers of flurbiprofen lowered Aβ42 levels to the greatest extent. Because R-flurbiprofen reduces Aβ42 levels by targeting γ-secretase and has reduced side effects related to inhibition of cyclooxygenase (COX), it is an excellent candidate for clinical testing as an Aβ42 lowering agent." @default.
• W2103071556 created "2016-06-24" @default.
• W2103071556 creator A5008634601 @default.
• W2103071556 creator A5009355143 @default.
• W2103071556 creator A5012931516 @default.
• W2103071556 creator A5028674788 @default.
• W2103071556 creator A5058688886 @default.
• W2103071556 creator A5059959394 @default.
• W2103071556 creator A5070988867 @default.
• W2103071556 creator A5074736964 @default.
• W2103071556 creator A5080933567 @default.
• W2103071556 creator A5084192983 @default.
• W2103071556 creator A5084447225 @default.
• W2103071556 date "2003-08-01" @default.
• W2103071556 modified "2023-10-18" @default.
• W2103071556 title "NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo" @default.
• W2103071556 cites W1483703465 @default.
• W2103071556 cites W1516026106 @default.
• W2103071556 cites W1534001036 @default.
• W2103071556 cites W1896225205 @default.
• W2103071556 cites W1929267935 @default.
• W2103071556 cites W1967549235 @default.
• W2103071556 cites W1969516175 @default.
• W2103071556 cites W1971541082 @default.
• W2103071556 cites W1975641519 @default.
• W2103071556 cites W1980906872 @default.
• W2103071556 cites W1990221452 @default.
• W2103071556 cites W1993198499 @default.
• W2103071556 cites W2001210466 @default.
• W2103071556 cites W2005681172 @default.
• W2103071556 cites W2016575029 @default.
• W2103071556 cites W2019970339 @default.
• W2103071556 cites W2041355017 @default.
• W2103071556 cites W2042706422 @default.
• W2103071556 cites W2046454316 @default.
• W2103071556 cites W2047613132 @default.
• W2103071556 cites W2047658053 @default.
• W2103071556 cites W2058614488 @default.
• W2103071556 cites W2062719785 @default.
• W2103071556 cites W2068477037 @default.
• W2103071556 cites W2075829521 @default.
• W2103071556 cites W2083556882 @default.
• W2103071556 cites W2087932565 @default.
• W2103071556 cites W2092698227 @default.
• W2103071556 cites W2096012124 @default.
• W2103071556 cites W2099556509 @default.
• W2103071556 cites W2101077392 @default.
• W2103071556 cites W2103440561 @default.
• W2103071556 cites W2104337029 @default.
• W2103071556 cites W2104634899 @default.
• W2103071556 cites W2108126051 @default.
• W2103071556 cites W2113690827 @default.
• W2103071556 cites W2116784956 @default.
• W2103071556 cites W2120673137 @default.
• W2103071556 cites W2126800086 @default.
• W2103071556 cites W2137497029 @default.
• W2103071556 cites W2140131793 @default.
• W2103071556 cites W2153723509 @default.
• W2103071556 cites W2163110760 @default.
• W2103071556 cites W2169152986 @default.
• W2103071556 cites W4231756144 @default.
• W2103071556 cites W4231800698 @default.
• W2103071556 cites W4237045660 @default.
• W2103071556 cites W4296759652 @default.
• W2103071556 cites W84124737 @default.
• W2103071556 doi "https://doi.org/10.1172/jci18162" @default.
• W2103071556 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/166298" @default.
• W2103071556 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12897211" @default.
• W2103071556 hasPublicationYear "2003" @default.
• W2103071556 type Work @default.
• W2103071556 sameAs 2103071556 @default.
• W2103071556 citedByCount "458" @default.
• W2103071556 countsByYear W21030715562012 @default.
• W2103071556 countsByYear W21030715562013 @default.
• W2103071556 countsByYear W21030715562014 @default.
• W2103071556 countsByYear W21030715562015 @default.
• W2103071556 countsByYear W21030715562016 @default.
• W2103071556 countsByYear W21030715562017 @default.
• W2103071556 countsByYear W21030715562018 @default.
• W2103071556 countsByYear W21030715562019 @default.
• W2103071556 countsByYear W21030715562020 @default.
• W2103071556 countsByYear W21030715562021 @default.
• W2103071556 countsByYear W21030715562022 @default.
• W2103071556 countsByYear W21030715562023 @default.
• W2103071556 crossrefType "journal-article" @default.
• W2103071556 hasAuthorship W2103071556A5008634601 @default.
• W2103071556 hasAuthorship W2103071556A5009355143 @default.
• W2103071556 hasAuthorship W2103071556A5012931516 @default.
• W2103071556 hasAuthorship W2103071556A5028674788 @default.
• W2103071556 hasAuthorship W2103071556A5058688886 @default.
• W2103071556 hasAuthorship W2103071556A5059959394 @default.
• W2103071556 hasAuthorship W2103071556A5070988867 @default.
• W2103071556 hasAuthorship W2103071556A5074736964 @default.
• W2103071556 hasAuthorship W2103071556A5080933567 @default.
• W2103071556 hasAuthorship W2103071556A5084192983 @default.
• W2103071556 hasAuthorship W2103071556A5084447225 @default.
• W2103071556 hasBestOaLocation W21030715561 @default.
• W2103071556 hasConcept C150903083 @default.

• next